Literature DB >> 11392471

Taurine modulates arginine vasopressin-mediated regulation of renal function.

M S Mozaffari1, D Schaffer.   

Abstract

Taurine has been implicated in the regulation of arginine vasopressin (AVP) secretion, and we have previously shown altered renal excretory function in the taurine-depleted rat. To further elucidate the role of taurine in AVP-mediated renal responses, the effects of an antagonist for renal AVP receptors were examined in four groups of conscious rats: control, taurine-supplemented, taurine-depleted, and taurine-repleted. Control and taurine-supplemented rats displayed similar and significant AVP receptor antagonist-induced elevations in fluid excretion, sodium excretion, and free water clearance but a marked reduction in urine osmolality. These effects are consistent with inhibition of endogenous AVP activity. By contrast, in the taurine-depleted rats, the magnitude and the time course of drug-induced renal excretory responses lagged behind those of the control and taurine-supplemented groups. Further, baseline urine osmolality was significantly higher in the taurine-depleted compared with the control or taurine-supplemented groups. However, after administration of the antagonist, taurine-depleted rats manifested a delayed but more marked reduction in urine osmolality, thereby eliminating the baseline differential that existed between the taurine-depleted rats and control or taurine-supplemented groups. Consistent with these observations, plasma AVP was significantly increased in the taurine-depleted compared with the control rats. Interestingly, taurine repletion shifted all responses closer to the control group. Analysis of the data suggests that the effect of the antagonist on renal excretory function is related primarily to altered tubular reabsorption activity. These observations suggest that taurine modulates renal function, and, thereby, body fluid homeostasis, through an AVP-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11392471     DOI: 10.1097/00005344-200106000-00012

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Impaired ability to increase water excretion in mice lacking the taurine transporter gene TAUT.

Authors:  Dan Yang Huang; Krishna M Boini; Philipp A Lang; Florian Grahammer; Michael Duszenko; Birgit Heller-Stilb; Ulrich Warskulat; Dieter Häussinger; Florian Lang; Volker Vallon
Journal:  Pflugers Arch       Date:  2005-10-26       Impact factor: 3.657

2.  Role of taurine in the vasculature: an overview of experimental and human studies.

Authors:  Worku Abebe; Mahmood S Mozaffari
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

3.  Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury.

Authors:  Mahmood S Mozaffari; Rafik Abdelsayed; Champa Patel; Hereward Wimborne; Jun Yao Liu; Stephen W Schaffer
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

4.  Proton Nuclear Magnetic Resonance (¹H-NMR)-Based Metabolomic Evaluation of Human Renal Allografts from Donations After Circulatory Death.

Authors:  Zijie Wang; Haiwei Yang; Chunchun Zhao; Jifu Wei; Junsong Wang; Zhijian Han; Jun Tao; Zhen Xu; Xiaobin Ju; Ruoyun Tan; Min Gu
Journal:  Med Sci Monit       Date:  2017-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.